Vimarsana
Biggest News Aggregation in the World

Page 7 - Microclave Clear News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Microclave Clear. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Microclave Clear Today - Breaking & Trending Today

Virginia Retirement Systems ET AL Decreases Holdings in ICU Medical, Inc. (NASDAQ:ICUI) - Vimarsana News

Virginia Retirement Systems ET AL Decreases Holdings in ICU Medical, Inc. (NASDAQ:ICUI)

Virginia Retirement Systems ET AL trimmed its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI – Get Rating) by 3.4% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 5,700 shares of the medical instruments supplier’s stock after selling 200 shares during […]

ICU Medical (NASDAQ:ICUI) Sets New 52-Week Low at $165.72 - Vimarsana News

ICU Medical (NASDAQ:ICUI) Sets New 52-Week Low at $165.72

ICU Medical, Inc. (NASDAQ:ICUI – Get Rating) shares hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $165.72 and last traded at $165.72, with a volume of 105 shares changing hands. The stock had previously closed at $168.21. Several brokerages have recently weighed in on ICUI. TheStreet […]

Analysts Expect ICU Medical, Inc. (NASDAQ:ICUI) Will Post Earnings of $1.91 Per Share - Vimarsana News

Analysts Expect ICU Medical, Inc. (NASDAQ:ICUI) Will Post Earnings of $1.91 Per Share

Wall Street brokerages expect that ICU Medical, Inc. (NASDAQ:ICUI – Get Rating) will post $1.91 earnings per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for ICU Medical’s earnings, with the lowest EPS estimate coming in at $1.88 and the highest estimate coming in at $1.94. ICU […]

ICU Medical (NASDAQ:ICUI) Upgraded by Zacks Investment Research to Buy - Vimarsana News

ICU Medical (NASDAQ:ICUI) Upgraded by Zacks Investment Research to Buy

ICU Medical (NASDAQ:ICUI – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Wednesday, Zacks.com reports. The brokerage currently has a $245.00 price objective on the medical instruments supplier’s stock. Zacks Investment Research‘s price target indicates a potential upside of 15.46% from […]

Head to Head Comparison: H-CYTE (OTCMKTS:HCYT) and ICU Medical (NASDAQ:ICUI) - Vimarsana News

Head to Head Comparison: H-CYTE (OTCMKTS:HCYT) and ICU Medical (NASDAQ:ICUI)

H-CYTE (OTCMKTS:HCYT – Get Rating) and ICU Medical (NASDAQ:ICUI – Get Rating) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, risk, institutional ownership, earnings and analyst recommendations. Risk & Volatility H-CYTE has a beta of 0.99, indicating that […]